Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/36795
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNunes, Thiago Franchi [UNIFESP]
dc.contributor.authorSzejnfeld, Denis [UNIFESP]
dc.contributor.authorWanderley Xavier, Ana Carolina [UNIFESP]
dc.contributor.authorKater, Claudio Elias [UNIFESP]
dc.contributor.authorFreire, Fabio [UNIFESP]
dc.contributor.authorAndreoni, Cássio [UNIFESP]
dc.contributor.authorGoldman, Suzan Menasce [UNIFESP]
dc.date.accessioned2016-01-24T14:34:29Z
dc.date.available2016-01-24T14:34:29Z
dc.date.issued2013-10-01
dc.identifierhttp://dx.doi.org/10.1007/s00261-013-9995-6
dc.identifier.citationAbdominal Imaging. New York: Springer, v. 38, n. 5, p. 1130-1135, 2013.
dc.identifier.issn0942-8925
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/36795
dc.description.abstractPercutaneous ablation of functioning adrenal adenomas has been an alternative to videolaparoscopic treatment. This study aimed to evaluate the feasibility, safety and efficacy of radiofrequency ablation (RFA) in the treatment of functioning adrenal tumors using a computed tomography (CT)-guided percutaneous technique as demonstrated by our experience and the literature.Eleven adult patients (mean age 46 years) with a diagnosis of functioning adrenal adenoma underwent CT-guided RFA between October 2011 and August 2012. All RFA procedures were performed using a needle electrode with a single lateral filament and the RITA(A (R)) 1500X radiofrequency generator. the RFA protocol consisted of two cycles of 5 min each with 1-min interval, with no additional ablation cycles. Contrast-enhanced CT scans were obtained and analyzed for immediate treatment success and possible complications.Maximum tumor dimension ranged from 1.2 to 3.4 cm. the mean procedure time was 74 min, and length of hospital stay ranged from 0.9 to 3.2 days (mean 1.8 days). One patient had residual pneumothorax and one patient had neuritis involving the T10 dermatome. of 11 patients, 10 recovered from their condition. Only one patient remained with hyperaldosteronism, but with reduced anti-hypertensive medication.CT-guided percutaneous RFA was a safe and effective treatment for functioning adrenal adenomas, with short hospital length of stay and low complication rate.en
dc.format.extent1130-1135
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofAbdominal Imaging
dc.rightsAcesso restrito
dc.subjectAblationen
dc.subjectRadiofrequencyen
dc.subjectAdrenal adenomaen
dc.subjectComputed tomographyen
dc.titlePercutaneous ablation of functioning adrenal adenoma: a report on 11 cases and a review of the literatureen
dc.typeResenha
dc.rights.licensehttp://www.springer.com/open+access/authors+rights?SGWID=0-176704-12-683201-0
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.description.affiliationUniversidade Federal de São Paulo UNIFESP, Dept Diagnost Imaging, BR-04024000 São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Div Endocrinol, Steroid Lab, BR-04039032 São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Dept Med, Div Clin Med, BR-04039002 São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Dept Surg, Div Urol, BR-04024002 São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo UNIFESP, Dept Diagnost Imaging, BR-04024000 São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Div Endocrinol, Steroid Lab, BR-04039032 São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Med, Div Clin Med, BR-04039002 São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Surg, Div Urol, BR-04024002 São Paulo, Brazil
dc.identifier.doi10.1007/s00261-013-9995-6
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000324325900023
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.